1st quartile Urate: 0.8–4.7 mg/dl | 2nd quartile Urate: 4.8–5.5 mg/dl | 3rd quartile Urate: 5.6–6.4 mg/dl | 4th quartile Urate: 6.5–12.9 mg/dl | |
---|---|---|---|---|
Metabolic syndrome | ||||
Crude | 1.00 | 1.29 (0.87–1.93) | 1.13 (0.77–1.66) | 1.48 (0.99–2.23) |
Adjusted | 1.00 | 1.17 (0.68–2.00) | 0.82 (0.49–1.37) | 0.71 (0.40–1.25) |
High WHtR | ||||
Crude | 1.00 | 1.10 (0.73–1.66) | 1.16 (0.78–1.74) | 1.35 (0.88–2.07) |
Adjusted | 1.00 | 1.08 (0.71–1.64) | 1.12 (0.75–1.70) | 1.27 (0.82–1.97) |
Hypertension | ||||
Crude | 1.00 | 1.36 (0.91–2.02) | 1.31 (0.89–1.93) | 1.97 (1.30–2.98)** |
Adjusted | 1.00 | 1.25 (0.80–1.95) | 1.13 (0.74–1.74) | 1.55 (0.98–2.45) |
Hyper-triglyceridemia | ||||
Crude | 1.00 | 1.34 (0.88–2.05) | 1.39 (0.92–2.10) | 1.76 (1.15–2.68)** |
Adjusted | 1.00 | 1.25 (0.81–1.92) | 1.22 (0.80–1.89) | 1.45 (0.92–2.29) |
Hypo-HDL cholesterolemia | ||||
Crude | 1.00 | 1.75 (0.98–3.12) | 1.39 (0.78–2.50) | 1.87 (1.04–3.34)** |
Adjusted | 1.00 | 1.68 (0.92–3.06) | 1.55 (0.83–2.87) | 1.86 (0.97–3.57) |